APA (7th ed.) Citation

Kandula, M., Sunil Kumar, K., Palanichamy, S., & Rampal, A. (2016). Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases. International Immunopharmacology, 40, 443. https://doi.org/10.1016/j.intimp.2016.09.013

Chicago Style (17th ed.) Citation

Kandula, Mahesh, KB Sunil Kumar, Sivanesan Palanichamy, and Ashok Rampal. "Discovery and Preclinical Development of a Novel Prodrug Conjugate of Mesalamine with Eicosapentaenoic Acid and Caprylic Acid for the Treatment of Inflammatory Bowel Diseases." International Immunopharmacology 40 (2016): 443. https://doi.org/10.1016/j.intimp.2016.09.013.

MLA (9th ed.) Citation

Kandula, Mahesh, et al. "Discovery and Preclinical Development of a Novel Prodrug Conjugate of Mesalamine with Eicosapentaenoic Acid and Caprylic Acid for the Treatment of Inflammatory Bowel Diseases." International Immunopharmacology, vol. 40, 2016, p. 443, https://doi.org/10.1016/j.intimp.2016.09.013.